Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Twin Helix is an Italian life science tools and research services company that supplies laboratory instruments, reagents, consumables, biobanking solutions, and technical services to researchers. The company focuses on molecular and cellular biology, immunology, laboratory instrumentation, and translational research support rather than developing its own therapeutic drug pipeline. Its offering includes distribution of products from international partners as well as custom services such as oligonucleotide synthesis, gene synthesis, CRISPR-edited mammalian cell lines, antibody services, peptide/protein production, cell line generation, and oncology-focused in vitro/in vivo drug efficacy studies. Twin Helix also supports biobanking and sample management through storage, labeling, process validation, custom software, and robotic solutions. The company primarily serves Italian customers in life sciences, biotechnology, pharmaceutical, advanced diagnostics, and related research markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Twin Helix.